Join over 15,000 leaders for the American Heart Association (AHA) at the AHA 2023 Scientific Sessions in Chicago, IL. Against this backdrop, five health start-up finalists with game-changing technologies in the treatment and prevention of cardiovascular disease will get the opportunity to pitch their companies to a panel of distinguished judges, top physicians, industry leaders, and VIPs in hopes of winning the AHA Health Tech Competition. The competition is held in The Health Innovation Pavilion, the pulse of the Science & Technology Hall!
Click here to learn more about the CHTI Health Innovation Pavilion and Programming
The American Heart Association Center for Health Technology & Innovation named RCE Technologies the winner of its annual Health Tech Competition during Scientific Sessions 2023.
RCE Technologies, Inc. (RCE) is an innovative artificial intelligence (AI) based medical technology company dedicated to early heart attack detection.
Cornell University
The Scanlon Group
Laerdal Million Lives Fund
Medtech Advantage Fund
Beam & Associates
Yale School of Medicine
AdventHealth Medical Group
Duke University School of Medicine
UT Southwestern Medical Center
Meta Platforms
NIH
Stanford Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
University of Michigan Helmsley Charitable Trust
Houston Cardiology Consultants
A no-code software platform that transforms clinical content — guidelines, algorithms, pathways and checklists — into “virtual clinical consults” available instantly at the point-of-care on standalone web/mobile apps and in the electronic health records.
Forest Devices is a medical device startup located in Pittsburgh, Pennsylvania. They are the creators of ALPHASTROKE, the first stroke and Large Vessel Occlusion (LVO) detection device that can potentially be used by first responders to triage patients directly to the right hospital.
Eko brings together advanced stethoscopes and intelligent detection software. Our mission is to help clinicians detect early signs of heart and lung disease with greater confidence for timely intervention and exceptional patient care.
AortixTM is a percutaneous mechanical circulatory support (pMCS) device designed to treat heart failure patients who are too sick for medication alone.
The idea behind Twiage came at a healthcare hackathon when an EMT and physician shared each other's frustration regarding the chaotic state of pre-hospital communication and the lack of preparation from hospitals for EMS arrivals. They saw...
Constant Therapy believes that large scale data and AI, which has augmented our lives in other areas, can support us when we need it most: to help the brain recover from injury or decline, and to inform new advances in brain health. Today they ...
